Skip to content
Research Article Open access CC BY 3.0

Farnesol Sensitivity of Serum Induced Yeast to Hyphae Morphogenesis: A Study on Fifty Clinical Isolates of Candida albicans

Vimal S. Rathod, Jayant S. Raut, Sharmila S. Raut, Sanjay R. More, Sankunny Mohan Karuppayil

Microbiology Research Journal International · pp. 150–157 · Published 12 Mar 2013

10.9734/BMRJ/2013/2939

Abstract

Aim: Objective of this study was to examine farnesol sensitivity of yeast to hyphae dimorphism in clinical isolates of Candida albicans. Study Design: Variations in virulence attributes contribute to variations in pathogenicity of C. albicans. Ability to switch from yeast to hyphae morphology is an important virulence factor. Farnesol, a quorum sensing molecule is known to play an important role in the regulation of C. albicans morphogenesis. Analysis of farnesol susceptibility of yeast to hyphae conversion may reveal a factor responsible for variation in pathogenicity among clinical isolates of C. albicans. Place and Duration of Study: SCG Medical College & SGGS Memorial Hospital, and School of Life Sciences, SRTM University, Nanded, India. Duration of this study was, December 2008 to December 2010. Methodology: Fifty clinical isolates of C. albicans were recovered from body fluids (such as, sputum, blood, urine, vaginal swab, tracheal swab, throat swab, feces, pus and cerebrospinal fluid, etc.) of patients with different clinical manifestations, in the tertiary care center hospital. Presumptive identification of C. albicans was done on HiCHROM agar-Candida, while confirmation was done by Germ tube formation assay, Carbohydrate assimilation and Corn meal agar test. Serum induced yeast to hyphae morphogenesis in C. albicans was performed in 96 well plates. Recent methodology of micro broth dilution was used for farnesol susceptibility testing in fifty clinical isolates. Results: Farnesol prevented hyphae formation in a concentration dependent manner, in the range 25 to 400 µM. Inhibition of ≥ 50% hyphae was considered as significant reduction in morphogenesis. MIC70 for farnesol mediated inhibition of morphogenesis in C. albicans was at 200 µM. Mean values for percentage inhibition of morphogenesis in fifty strains was compared by analysis of variance (ANOVA). P = 0.05 was considered significant. Conclusion: Susceptibility of yeast to hyphae morphogenesis to the quorum sensing molecule farnesol, varied significantly among clinical isolates of C. albicans. We hypothesize that variation in farnesol sensitivity may be a factor responsible for variable dissemination and infection ability of C. albicans.

Candida albicans biofilm farnesol morphogenesis quorum sensing sensitivity virulence

References (23)

  1. 1 Growth of Candida albicans hyphae [DOI]
  2. 2 Quorum Sensing in the Dimorphic Fungus Candida albicans Is Mediated by Farnesol [DOI]
  3. 3 Medically Important Fungi: A Guide to Identification
  4. 4 Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections [DOI]
  5. 5 Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule [DOI]
  6. 6 EngineeredControl of Cell Morphology In Vivo Reveals Distinct Roles for Yeast andFilamentous Forms of Candida albicans duringInfection [DOI]
  7. 7 Candida albicans, a major human fungal pathogen [DOI]
  8. 8 Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model [DOI]
  9. 9 Quorum Sensing in Dimorphic Fungi: Farnesol and Beyond [DOI]
  10. 10 Transcription factors in Candida albicans – environmental control of morphogenesis [DOI]
  11. 11 Production of Tyrosol by Candida albicans Biofilms and Its Role in Quorum Sensing and Biofilm Development [DOI]
  12. 12 Pathogenicity and drug resistance in Candida albicans and other yeast species [DOI]
  13. 13 Effect of Farnesol on a Mouse Model of Systemic Candidiasis, Determined by Use of a DPP3 Knockout Mutant of Candida albicans [DOI]
  14. 14 Farnesol Concentrations Required To Block Germ Tube Formation in Candida albicans in the Presence and Absence of Serum [DOI]
  15. 15 Enhanced Production of Farnesol by Candida albicans Treated with Four Azoles [DOI]
  16. 16 Morphogenesis Control in Candida albicans and Candida dubliniensis through Signaling Molecules Produced by Planktonic and Biofilm Cells [DOI]
  17. 17 In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest [DOI]
  18. 18 Protective effects of farnesol against oral candidiasis in mice [DOI]
  19. 19 Activity and Toxicity of Farnesol towards Candida albicans Are Dependent on Growth Conditions [DOI]
  20. 20 Cell Surface Hydrophobicity and Adhesion: A Study on Fifty Clinical Isolates of Candida albicans [DOI]
  21. 21 Biofilm formation by Candida albicans on various prosthetic materials and its fluconazole sensitivity: a kinetic study [DOI]
  22. 22 A morphogenetic regulatory role for ethyl alcohol in Candida albicans [DOI]
  23. 23 Evaluation of Morphogenic Regulatory Activity of Farnesoic acid and Its Derivatives against Candida albicans Dimorphism [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

89

Page views

0

PDF downloads

34

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.